Wednesday, June 3, 2020

COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report

COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report Gilead Sciences#39; experimental drug Remdesivir has been found to aid in the recovery of COVID-19 patients.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-gilead-says-indian-licensees-free-to-price-remdesivir-report_13859421.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...